Important from YMB CYDY SUING 13D POINTS: 1) Cydy is

New Post Public Reply Private Reply Replies (0) Message Board
Cycl2R
1,414
Important from YMB

CYDY SUING 13D POINTS:

1) Cydy is NOT suing for monetary damages! Too many people assume when you sue someone it's for money.

Chancery court is for deciding aspects of equity. Not seeking reparations for damages. Case was filed in Delaware chancery court. (Not every state even has a chancery court because of its specific purpose). In fact, there are no juries in Chancery court. It's all adjudicated by judges.

Chancery court is for suing to obtain some form of non-monetary award.

We actually know from the court filing what this is. Cytodyn is seeking an injunction against 13D group from making statements about their goals, aims, etc because they have misled investors that caused a drop in SP. In essence the lawsuit is to silence them under order (gag order if you will)

2) Proof of claims: Cytodyn claims are a binary event and the 13D group doesn't have any real wiggle room.

Did 13D file documents that didn't expose former BOD, employees, and relationship with Bruce P. Which led to investors being misled as to 13D intentions? We know the answer to this is yes and there are fifty such (and I am certain Sidley has verified) infractions.

Since 13D can't argue the filing wasn't missing the info, they could argue the information itself is wrong. Did Dr. P work previously with Cytodyn and a proposed buyout that went south? Did he try to patent material not his? Did Caracciolo and Pestell previously work for Cytodyn?

We know these facts to be true as well.

So 13D can't say the facts they left out are incorrect and they can't say they didn't leave them out.

The chancery court is giving them five days for an answer but without a rabbit from a hat, this case is going to be decided rather quickly.

3) a long drawn out court case? No, it appears there has been a request to expedite. For the reasons listed above this seems most likely. Doubtful this case is going to cost millions as people suggest or fear.

3) NP has made a tactical error by opening himself up to deposition? This is just FUD. The suit is actually very target specific. It's designed to shut up the 13D group. Even if it did get dragged out, saying NP deceived investors is not an excuse for 13D deceiving investors. If that's the defense tactic they are on their way to a major loss. But it's almost certainly not going that direction. Again this about forcing 13D to no longer make comments or seek the proxy vote.

4) the death knell for 13D. With 13D disqualified from the proxy vote and if Cytodyn wins this case, the 13D ordered by chancery court to cease and desist, that's the end of 13D.

5) Why spend the money on this? Some posters are saying this is just a greedy means for current BOD to keep their jobs. Probably but who wouldn't try to keep their job especially if they have done the hard work of a decade and someone else is trying to steal it at the gates to success?

But as some posters have hypothesized, this may actually be a means to discuss a merger with big pharma.

Don't let the bashers deceive you. They keep saying no merger can happen with a lawsuit hanging over Cytodyn head. Correct, so ask yourself why Cytodyn filed this suit?

My theory:. No big pharma will discuss a merger with a proxy battle ongoing. The suit as mentioned above is to completely crush and eradicate the 13D proxy battle. Once that is out of the way, any merger discussion can be resumed.

If that is the purpose of the lawsuit, to pave the way for a merger, then it appears to be well justified in my opinion.
Less
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading
ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 2

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 4

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
TCL’s AI Vision: Immersive Living at IFA 2026

Updated Category News Views 1

AI and Displays: A Match Made in Tech Heaven Every so often, a company stands up at a tech fair and gives a glimpse into the next chapter of living, as TCL did at IFA 2026. This time, they're not just talking about screens; they're weaving them into the fabric of everyday life alongside AI capabilities. From sporting arenas to your living room, it's a vision of what could...

Continue Reading
See's Candies Data Breach Spurs Legal Scrutiny

Updated Category News Views 12

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Updated Category News Views 3

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 0

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading

Top 5 Most Recently Viewed Articles

BioCryst Pharmaceuticals Celebrates ORLADEYO's Landmark Approval

Updated Category News Views 152

BioCryst Pharmaceuticals Achieves Significant Reimbursement Milestone BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has made a significant stride in the healthcare market by securing reimbursement for ORLADEYO (berotralstat) across major European nations. This breakthrough follows a positive recommendation from the Zorginstituut Nederland, leading to ORLADEYO's approval...

Continue Reading
Zoom Communications Achieves Award for Broadcast Innovation Success

Updated Category News Views 296

Zoom Communications Triumphs with Emmy Award Recognition In an impressive showcase of innovation, Zoom Communications, Inc. (NASDAQ: ZM) has received the prestigious Engineering, Science & Technology Emmy® Award. This accolade honors the company's revolutionary Zoom for Broadcast technology, which plays a significant role in enhancing broadcast capabilities across...

Continue Reading
Israel Acquisitions Corp. Reaches New Heights in Stock Prices

Updated Category News Views 46

Israel Acquisitions Corp. Achieves Significant Stock Milestone In a remarkable turn of events, shares of Israel Acquisitions Corp. (ISRL) have soared to a 52-week high, trading at an impressive $11.21. This achievement signifies a crucial milestone in the company's journey, showcasing its robust performance over the past year. The rising confidence among investors is...

Continue Reading
Oculis Advances Transformative Eye Drop Therapy for DME

Updated Category News Views 138

Oculis’ Innovative Approach to Treat Diabetic Macular Edema Oculis Holding AG (Nasdaq: OCS), a pioneering biopharmaceutical company dedicated to enhancing eye health, has made significant strides in treating diabetic macular edema (DME) through its revolutionary OCS-01 eye drops. These high-concentration dexamethasone eye drops are formulated with Oculis' unique...

Continue Reading
Pony AI Inc. Secures Permit for Driverless Robotaxi Services

Updated Category News Views 208

Pony AI Inc. Achieves Major Milestone in Autonomous Mobility Pony AI Inc. has made headlines recently by receiving a permit to operate fully driverless commercial robotaxi services in various urban districts. This remarkable announcement came during a significant event focused on artificial intelligence, signaling an important transition in the way transportation services...

Continue Reading